The End Game: Payer Engagement Webinar
November 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical
In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
Cellectis given another shot at off-the-shelf CAR-T
November 8, 2017Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical
It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
Clinical trials still have a problem with ethnic minorities
November 8, 2017Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical
Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …
Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time
November 8, 2017Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma
Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …
Collaboration in Biopharma
November 7, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Dear Colleague,
Breathalyser for malaria shows promise in trials
November 7, 2017Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …
FDA expands Roche drug indication to approve first-ever treatment for rare blood cancer
November 7, 2017Manufacturing and Production, Sales and Marketing Cancer, Erdheim-Chester Disease, FDA, Roche, blood cancer, pharma
The FDA has announced the approval of Roche’s Zelboraf (vemurafenib) in the treatment of Erdheim-Chester Disease (ECD), expanding its already …
Takeda’s dengue vaccine surpasses Sanofi’s in P2 trial
November 7, 2017Manufacturing and Production, Sales and Marketing Sanofi, Takeda, biotech, drugs, pharma, pharmaceutical
Sanofi spent more than $1.5 billion and two decades to develop the first ever vaccine for dengue fever, only a …
Valeant backs away from female libido pill
November 7, 2017Manufacturing and Production, Sales and Marketing Addyi, Valeant, biotech, drugs, pharma, pharmaceutical
Only two years ago, Valeant was so keen to get involved with a pill reported to increase the female libido …
Clinical trial transparency: Letting the light in
November 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical
Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …
Merck KGaA posts promising osteoarthritis data
November 6, 2017Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …
Valeant begins long comeback trail with FDA approval
November 6, 2017Sales and Marketing Valeant, Vyzulta, biotech, drugs, pharma, pharmaceutical
Valeant has had precious little to be happy about over the last few years, it’s bounced from one piece of …
Gut bacteria may be key to efficacy of immunotherapies
November 6, 2017Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical
Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …
NHS to offer GP appointments via smartphone
November 6, 2017Medical Communications, Sales and Marketing GP at hand, NHS, biotech, drugs, pharma, pharmaceutical
It has been announced that I trial will begin in London offering the public GP consultations through their smartphone. The …
Novartis aims for CAR-T double-approval in Europe
November 6, 2017Sales and Marketing CAR-T, Gilead, Juno, Novartis, biotech, drugs, pharma, pharmaceutical
Just last week Novartis revealed it had applied to the FDA for a new indication in diffuse large B-cell lymphoma …
Top Ten most popular articles on Pharmafile.com this week
November 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten
As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
GSK’s R&D head to move on after shift in focus
November 3, 2017Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
There has been a raft of changes at senior levels of GSK since Emma Walmsley took over the role from …
Witty to lead way in fast-tracking medicine through UK system
November 3, 2017Medical Communications AAR, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
The UK government has announced its response to the Accelerated Access Review that was published last year, with former GSK …
GSK’s experimental multiple myeloma scores Breakthrough designation with FDA
November 3, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
Teva’s woes continue, as shares sink to 17-year low on Q3 results
November 2, 2017Medical Communications Mylan, Teva, biotech, drugs, pharma, pharmaceutical
Spare a thought for Kare Schultz, he agreed to take on the position of CEO at Teva at the start …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
